Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

О Lite Strategy

Основано2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Сообщество
Twitter
Website
Тэги
Publicly listed company
Crypto Stocks

Тенденция изменения индекса Горячих проектов

Нет записей

Состав команды

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

Подробности сбора средств

Post-IPO(2025-07-21)
Сумма₽7,33B
Оценка--